Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular

S Kuriyama1, T Nakatani, K Masui

  • 1Third Department of Internal Medicine, Nara Medical University, Japan.

Insights

Gene therapy using retroviral vectors can be enhanced by the bystander effect, where modified cells kill adjacent cancer cells. This study shows cell-cell contact is key for this effect in hepatocellular carcinoma treatment.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Gene therapy faces challenges in delivering genes to all target cells.
  • The bystander effect, or adjacent cell killing, offers therapeutic potential in cancer gene therapy.
  • Herpes simplex virus thymidine kinase (HSV-tk) gene transfer is a strategy for cancer treatment.

Purpose of the Study:

  • To investigate the role of cell-cell contact in the bystander effect for hepatocellular carcinoma (HCC) gene therapy.
  • To evaluate the therapeutic efficacy of HSV-tk gene transduction and ganciclovir treatment in HCC models.

Main Methods:

  • Murine and rat HCC cells were retrovirally transduced with the HSV-tk gene.
  • Transduced and parental HCC cells were co-cultured at varying densities in the presence of ganciclovir.
  • In vivo studies involved implanting mixtures of transduced and untransduced HCC cells in mice, followed by ganciclovir administration.

Main Results:

  • High-density co-culture of HSV-tk transduced and parental HCC cells with ganciclovir led to significant elimination of parental cells.
  • Low-density co-culture showed a weaker, but significant, bystander effect.
  • Cell lysates and conditioned media from transduced cells showed minimal bystander effect.
  • In vivo experiments demonstrated that ganciclovir administration inhibited tumor development in mice bearing mixed HCC cell implants.

Conclusions:

  • Cell-cell contact is the primary mechanism driving the bystander effect in HSV-tk/ganciclovir gene therapy for HCC.
  • A minor contribution from cytotoxic substances released by transduced cells was observed.
  • The HSV-tk/ganciclovir gene therapy approach is feasible for treating hepatocellular carcinoma both in vitro and in vivo.